NeoGenomics NEO Stock
NeoGenomics Price Chart
NeoGenomics NEO Financial and Trading Overview
| NeoGenomics stock price | 14.29 USD |
| Previous Close | 14.11 USD |
| Open | 13.98 USD |
| Bid | 10.16 USD x 200 |
| Ask | 17.8 USD x 200 |
| Day's Range | 13.85 - 14.24 USD |
| 52 Week Range | 4.72 - 15.57 USD |
| Volume | 1.48M USD |
| Avg. Volume | 2.65M USD |
| Market Cap | 1.84B USD |
| Beta (5Y Monthly) | 1.738 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.77 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.67 USD |
NEO Valuation Measures
| Enterprise Value | 2.1B USD |
| Trailing P/E | N/A |
| Forward P/E | 38.705254 |
| PEG Ratio (5 yr expected) | 2.09 |
| Price/Sales (ttm) | 2.462955 |
| Price/Book (mrq) | 2.2074466 |
| Enterprise Value/Revenue | 2.815 |
| Enterprise Value/EBITDA | 492.073 |
Trading Information
NeoGenomics Stock Price History
| Beta (5Y Monthly) | 1.738 |
| 52-Week Change | 96.51% |
| S&P500 52-Week Change | 20.84% |
| 52 Week High | 15.57 USD |
| 52 Week Low | 4.72 USD |
| 50-Day Moving Average | 10.91 USD |
| 200-Day Moving Average | 10.4 USD |
NEO Share Statistics
| Avg. Volume (3 month) | 2.65M USD |
| Avg. Daily Volume (10-Days) | 3.03M USD |
| Shares Outstanding | 130.21M |
| Float | 118.27M |
| Short Ratio | 3.35 |
| % Held by Insiders | 2.05% |
| % Held by Institutions | 108.33% |
| Shares Short | 11.62M |
| Short % of Float | 10.51% |
| Short % of Shares Outstanding | 8.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -13.29% |
| Operating Margin (ttm) | -9.34% |
| Gross Margin | 43.10% |
| EBITDA Margin | 0.57% |
Management Effectiveness
| Return on Assets (ttm) | -2.63% |
| Return on Equity (ttm) | -11.55% |
Income Statement
| Revenue (ttm) | 745.97M USD |
| Revenue Per Share (ttm) | 5.8 USD |
| Quarterly Revenue Growth (yoy) | 11.09% |
| Gross Profit (ttm) | 321.51M USD |
| EBITDA | 4.27M USD |
| Net Income Avi to Common (ttm) | -99208000 USD |
| Diluted EPS (ttm) | -0.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 146.14M USD |
| Total Cash Per Share (mrq) | 1.12 USD |
| Total Debt (mrq) | 408.53M USD |
| Total Debt/Equity (mrq) | 49.29 USD |
| Current Ratio (mrq) | 4.418 |
| Book Value Per Share (mrq) | 6.392 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.42M USD |
| Levered Free Cash Flow (ttm) | 33.17M USD |
Profile of NeoGenomics
| Country | United States |
| State | FL |
| City | Fort Myers |
| Address | 9490 NeoGenomics Way |
| ZIP | 33912 |
| Phone | 239 768 0600 |
| Website | https://www.neogenomics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 2500 |
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Q&A For NeoGenomics Stock
What is a current NEO stock price?
NeoGenomics NEO stock price today per share is 14.29 USD.
How to purchase NeoGenomics stock?
You can buy NEO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeoGenomics?
The stock symbol or ticker of NeoGenomics is NEO.
Which industry does the NeoGenomics company belong to?
The NeoGenomics industry is Diagnostics & Research.
How many shares does NeoGenomics have in circulation?
The max supply of NeoGenomics shares is 130.21M.
What is NeoGenomics Price to Earnings Ratio (PE Ratio)?
NeoGenomics PE Ratio is now.
What was NeoGenomics earnings per share over the trailing 12 months (TTM)?
NeoGenomics EPS is -0.77 USD over the trailing 12 months.
Which sector does the NeoGenomics company belong to?
The NeoGenomics sector is Healthcare.
NeoGenomics NEO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26107.71 USD — |
<0.01
|
3.46B USD — | 26041.13 USD — | 26316.81 USD — | — - | 3.46B USD — |
|
US Tech Composite Total Return
XCMP
US
|
32188.86 USD — |
-0.05
|
— — | 32125.24 USD — | 32465.34 USD — | — - | — — |
|
US Tech US 700 Small Cap Value N
NQUS700SCVN
US
|
3148.73 USD — |
+0.64
|
— — | 3139.16 USD — | 3167.67 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3173.08 USD — |
+0.24
|
— — | 3165.92 USD — | 3192.38 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1249.66 USD — |
+0.68
|
— — | 1233.72 USD — | 1252.43 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
139.24 USD — |
-0.76
|
— — | 138.5 USD — | 141.42 USD — | — - | — — |
|
US Tech US 700 Small Cap Value I
NQUS700SCV
US
|
2747.71 USD — |
+0.63
|
— — | 2739.36 USD — | 2764.24 USD — | — - | — — |
- {{ link.label }} {{link}}